New research suggests that individuals who come off popular weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who halt conventional lifestyle plans.
Published data in a prominent medical journal demonstrates that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"Individuals buying these treatments should be aware of the risk of quick rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.
This pace of recovery means a reversion to original weight in about 18 months.
Weighing Treatments
The study, which examined 37 of trials involving thousands of patients, contrasted the results of these new drugs with older methods.
Researchers note that people who lose weight through lifestyle changes alone usually experience a less rapid creep back—approximately 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Nutrition scientists propose the mechanism of the jabs accounts for the heightened rebound.
The injections imitate a body's own chemical called GLP-1, which moderates hunger.
"Long-term administration of the hormone levels several times higher than normal might result in the body to produce less of its endogenous GLP-1, and could lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' means appetite is uncontrolled, making overeating far more likely."
A Lifelong Condition?
Health authorities recommend the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts say that, considering the likelihood of relapse, the therapy might need to be ongoing.
This perspective is supported by drug manufacturers, who note that the findings "underscore the chronic nature of excess weight," similar to managing conditions like diabetes.
User Accounts
Users who have come off the jabs report a intense return of cravings.
"I experienced a switch that goes on and I was suddenly starving," recalled one woman.
The struggle is worsened if patients have not adopted lasting lifestyle or habit modifications during therapy.
Widespread Use
Survey data indicate that a significant number of adults in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is more common among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts stress that while these medications are effective tools for shedding pounds, they are not a magic fix and long-term success hinges on integrated behavioural management.
